526546 — Choksi Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹374.59m
- IN₹686.34m
- IN₹344.41m
- 61
- 56
- 28
- 45
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 337 | 282 | 257 | 300 | 344 |
Cost of Revenue | |||||
Gross Profit | 298 | 249 | 225 | 274 | 322 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 302 | 316 | 262 | 266 | 274 |
Operating Profit | 35.9 | -34.5 | -4.78 | 34.6 | 70 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.9 | -57.1 | -28.1 | 3.67 | 37.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16 | -38.8 | -26.1 | 2.07 | 32.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 16 | -38.8 | -26.1 | 2.07 | 32.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16 | -38.8 | -26.1 | 2.07 | 32.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.3 | -2.65 | -3.75 | 0.294 | 1.82 |
Dividends per Share |